Tuesday, May 30, 2006
New forms comming up
Currently, CIBMTR and NMDP are creating a new single series of Report Forms for submitting data to the 2 organizations. The expected release of the new Forms is later in 2006. The Registration Forms are being updated by CIBMTR and EBMTR, also with an anticipated 2006 release.
Diane Jacobi Knutson
Sr Research Associate
CIBMTR
Diane Jacobi Knutson
Sr Research Associate
CIBMTR
Tuesday, April 12, 2005
First Edition of Changes to the 002 Series of Core Insert
Changes in 5/04 version:
Q9 – took the “NOS” off of “American Indian, NOS”
Q185 – added “Oral and IV” check-box
Q788 – changed the variable number for “Other, specify”
Changes in 8/03 version:
Q645 – changed “post-DCI” to “post-HSCT”
Q472 – added variable 4 “Chronic GVHD flair (symptoms reactivate within 30 days of drug tapering or discontinuation)”
Changes in 5/03 version:
Q318 – changed “>28” to “>14” in the multiple transplants within 100 days section
viii on Institutional Information page – added “subsequent” before “reportable”
Changes in 4/03 version:
Page One – deleted “DAY 100” from the form title
Page Six – added “DCI = Donor Cellular Infusion” and “IT = Intrathecal” to abbreviations box
Page Ten – deleted “Unknown” from Q111, 119-123, 125, 132, and 139
Q168 – corrected spelling of “Adriamycin”
Page Eleven – adjusted header so it would line up
Page Twelve – removed “Conditioning” from bottom of page
Page Eighteen – changed “days” to “consecutive lab values” on Option 2
Q365 – removed the word “actual”
Q672 – changed “post-DCI” to “post-HSCT”
Q763 – changed to read “If patient received a DCI >14 days post HSCT, was therapy given to treat the patient’s disease between this HSCT and the next reportable DCI?”
vii on Institutional Information page – removed “DAY 100” from title box
viii on Institutional Information page – changed “34” to “16”
Q9 – took the “NOS” off of “American Indian, NOS”
Q185 – added “Oral and IV” check-box
Q788 – changed the variable number for “Other, specify”
Changes in 8/03 version:
Q645 – changed “post-DCI” to “post-HSCT”
Q472 – added variable 4 “Chronic GVHD flair (symptoms reactivate within 30 days of drug tapering or discontinuation)”
Changes in 5/03 version:
Q318 – changed “>28” to “>14” in the multiple transplants within 100 days section
viii on Institutional Information page – added “subsequent” before “reportable”
Changes in 4/03 version:
Page One – deleted “DAY 100” from the form title
Page Six – added “DCI = Donor Cellular Infusion” and “IT = Intrathecal” to abbreviations box
Page Ten – deleted “Unknown” from Q111, 119-123, 125, 132, and 139
Q168 – corrected spelling of “Adriamycin”
Page Eleven – adjusted header so it would line up
Page Twelve – removed “Conditioning” from bottom of page
Page Eighteen – changed “days” to “consecutive lab values” on Option 2
Q365 – removed the word “actual”
Q672 – changed “post-DCI” to “post-HSCT”
Q763 – changed to read “If patient received a DCI >14 days post HSCT, was therapy given to treat the patient’s disease between this HSCT and the next reportable DCI?”
vii on Institutional Information page – removed “DAY 100” from title box
viii on Institutional Information page – changed “34” to “16”
